New tRIBO-seq Method Reveals How Active tRNAs Drive Protein Synthesis

New tRIBO-seq Method Reveals How Active tRNAs Drive Protein Synthesis

Scientists Catch tRNAs in the Act, Rewriting How We See Cell Biology For decades, scientists have been taking a headcount, assuming it tells the whole story. Now, a new method published in Nature Methods reveals that assumption is wrong. News-Medical reported that researchers in Barcelona have developed a technique, called tRIBO-seq, that watches only the … Read more

Harvard Study Links Exercise Variety to Longer Life

Illustration of a person taking part in rowing, tennis, running, weightlifting, and cycling

A landmark Harvard study of 110,000 Americans has revealed that the variety of exercise, not just the volume, is linked to a longer life. The research, published in January 2026 by scientists at the Harvard School of Public Health, found that over a 30-year period, people who engaged in a greater variety of exercise were … Read more

Report: Taking Vitamin D and Omega-3 Together

Apple App Store

Taking vitamin D and omega-3 fatty acids together may improve the absorption of the fat-soluble vitamin and offer combined health benefits, potentially supporting healthy aging, brain function, and stronger bones, according to a recent report. Because vitamin D is fat-soluble, taking it with omega-3 fatty acids may improve its absorption, though the evidence for many … Read more

AI-Powered Smartwatch Study Detects Hypertension

AI-Powered Smartwatch Study Detects Hypertension

Smartwatch AI Detects High Blood Pressure Without a Cuff Imagine knowing you’re at risk for a dangerous blood pressure spike, all from the watch on your wrist. That’s the promise of a new study, which shows artificial intelligence can detect hypertension using only the sensors in a consumer smartwatch. The research, a prospective multicenter study … Read more

Enfortumab Vedotin Plus Pembrolizumab Achieves High pCR Rates in MIBC

Enfortumab Vedotin Plus Pembrolizumab Achieves High pCR Rates in MIBC

Enfortumab vedotin plus pembrolizumab has doubled the pathologic complete response rate in muscle-invasive bladder cancer (MIBC), reshaping bladder preservation approaches for patients too frail for standard chemotherapy. In the KEYNOTE-905/EV-303 trial of 344 cisplatin-ineligible patients, the combination achieved a pCR rate of 57.1% compared to 8.6% with no systemic therapy. For cisplatin-eligible patients in KEYNOTE-B15/EV-304, … Read more

AI Study Reveals Growth Patterns in Glioblastoma

AI Study Reveals Growth Patterns in Glioblastoma

Scientists have discovered a surprising pattern in glioblastoma, one of the most aggressive forms of brain cancer, that could reshape how researchers approach treatment. The finding suggests the cancer may not be the chaotic mass long believed, but instead follows a more organized, three-stage growth pattern that could be its undoing. LiveNOW from FOX reported … Read more